assays

News

A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.

News

Advances in therapeutics are outpacing the development of diagnostics due to policy and payment barriers, holding back effective, targeted care.

R&D

What makes a biomarker a biomarker?

R&D

As public funding becomes more uncertain, lab and clinical services professionals are increasingly being called on to help.

R&D

The fundamental questions in the trial phases of drug development are “Does it work?”, “Is it safe?”, and “What else do we need to know?”

Views & Analysis

The COVID-19 pandemic stopped the world in its tracks.